SEC Filing · 6-K
SOPHiA GENETICS SA
SOPHNASDAQEQUITYCurrent
SEC Filing
Company context
SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of SOPHiA DDM™, a platform that analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions.
Current securities
As-filed source
As filedOpen full document ↗